No.040 High Dose CBD Isolate Medicinal Capsules

$40.00 $110.00
4 people are viewing this right now
Clear
Estimated Delivery:
07 - 10 Nov, 2024

Description

100 mg | 200 mg Fast Acting Bluemasi CBD capsules

Bluemasi’s ultra high-dose therapeutic CBD capsules have been specially formulated to support healing, health and wellness. Produced using advanced scientific extraction tools and methods that deliver the purest CBD isolate without the THC effects, each capsule contains pure hemp-derived CBD isolate in an organic coconut carrier oil for optimal absorption.

  • 30 | 60 capsules of pure CBD isolate (no THC)
  • Dosage strength of 100 mg | 200 mg per capsule

About CBD Isolate Extract: A non-intoxicating compound found in cannabis, cannabidiol (CBD) is an excellent choice for those looking for the therapeutic benefits of cannabis while eliminating the psychoactive effects of THC. CBD is known to have immune-modulating, anti-inflammatory, and anti-oxidant effects, and is often used to treat chronic pain, anxiety, insomnia and nausea. See below for clinical trials that are investigating these and other uses of this remarkable compound. 

CBD isolate is a purified form of CBD derived from hemp that has had all other plant compounds removed, including delta-9 tetrahydrocannabinol (THC), the cannabinoid responsible for the mind altering “high” associated with cannabis.

CBD-3D-balls.png

Bluemasi’s advanced extraction processes remove oils and other compounds from hemp, leaving behind pure CBD in crystallized form. This ground crystal is then used to create precise product formulations and dosages.

Store at or below room temperature, away from heat and sunlight. Refrigeration is recommended where possible.

Keep this product safely away from children and pets.

Ingredients: CBD Isolate, Organic Coconut Oil, Gelatin Based Capsule.
This product contains no THC.

Scientific clinical trials exploring the therapeutic use of CBD:

Fine PG et al. The Endocannabinoid System, Cannabinoids, and Pain. Rambam Maimonides Med J 2013;4(4):e0022.
​​https://pubmed.ncbi.nlm.nih.gov/24228165/

Ko GD et al. Medical cannabis – the Canadian perspective. J Pain Res 2016;9:735-44.
https://pubmed.ncbi.nlm.nih.gov/27757048/

 

0